Literature DB >> 1579446

Identification of novel factors that bind to the PRD I region of the human beta-interferon promoter.

S T Whiteside1, K V Visvanathan, S Goodbourn.   

Abstract

Treatment of cells with virus or synthetic double-stranded RNA (dsRNA) leads to the transient transcriptional activation of the beta-interferon gene. Genetic analysis has revealed that the 5' regulatory sequence responsible for this induction contains multiple positive and negative elements. One of these, Positive Regulatory Domain I (PRD I), has been shown to bind the positively-acting transcription factor IRF-1. In this study we show that this element is inducible under conditions where IRF-1 cannot be detected, suggesting that additional cellular factors are involved in the induction process. To investigate the existence of such factors we have analysed the range and properties of PRD I-binding activities present in HeLa cells. In addition to the repressor protein IRF-2, several novel factors can bind to PRD I in uninduced cells: two of these have properties consistent with a role in negative regulation; levels of two others increase upon priming, and may be alternative candidates for activators. Upon induction we also observe a novel factor whose appearance does not depend upon de novo protein synthesis, and which appears to be a truncated form of IRF-2. The potential involvement of these factors in regulating the beta-interferon gene is discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1579446      PMCID: PMC312234          DOI: 10.1093/nar/20.7.1531

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  37 in total

1.  Absence of the type I IFN system in EC cells: transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated.

Authors:  H Harada; K Willison; J Sakakibara; M Miyamoto; T Fujita; T Taniguchi
Journal:  Cell       Date:  1990-10-19       Impact factor: 41.582

2.  Multimerization of AAGTGA and GAAAGT generates sequences that mediate virus inducibility by mimicking an interferon promoter element.

Authors:  D Näf; S E Hardin; C Weissmann
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

3.  Selection of sequences recognized by a DNA binding protein using a preparative southwestern blot.

Authors:  A D Keller; T Maniatis
Journal:  Nucleic Acids Res       Date:  1991-09-11       Impact factor: 16.971

Review 4.  The regulation of beta-interferon gene expression.

Authors:  S Goodbourn
Journal:  Semin Cancer Biol       Date:  1990-02       Impact factor: 15.707

5.  Overlapping positive and negative regulatory domains of the human beta-interferon gene.

Authors:  S Goodbourn; T Maniatis
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

6.  Interferon-alpha regulates nuclear translocation and DNA-binding affinity of ISGF3, a multimeric transcriptional activator.

Authors:  D S Kessler; S A Veals; X Y Fu; D E Levy
Journal:  Genes Dev       Date:  1990-10       Impact factor: 11.361

7.  Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes.

Authors:  F W Studier; B A Moffatt
Journal:  J Mol Biol       Date:  1986-05-05       Impact factor: 5.469

8.  Identification and characterization of a novel repressor of beta-interferon gene expression.

Authors:  A D Keller; T Maniatis
Journal:  Genes Dev       Date:  1991-05       Impact factor: 11.361

9.  Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-beta gene regulatory elements.

Authors:  M Miyamoto; T Fujita; Y Kimura; M Maruyama; H Harada; Y Sudo; T Miyata; T Taniguchi
Journal:  Cell       Date:  1988-09-09       Impact factor: 41.582

10.  Two different virus-inducible elements are required for human beta-interferon gene regulation.

Authors:  C M Fan; T Maniatis
Journal:  EMBO J       Date:  1989-01       Impact factor: 11.598

View more
  18 in total

1.  I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity.

Authors:  S T Whiteside; J C Epinat; N R Rice; A Israël
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

2.  Interferon-regulatory factors during development of CD4 and CD8 thymocytes.

Authors:  A K Simon; M Desrois; A M Schmitt-Verhulst
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

Review 3.  Negative regulation of transcription in eukaryotes.

Authors:  A R Clark; K Docherty
Journal:  Biochem J       Date:  1993-12-15       Impact factor: 3.857

4.  NF-kappa B-independent activation of beta-interferon expression in mouse F9 embryonal carcinoma cells.

Authors:  M J Ellis; S Goodbourn
Journal:  Nucleic Acids Res       Date:  1994-10-25       Impact factor: 16.971

5.  Inducible processing of interferon regulatory factor-2.

Authors:  V J Palombella; T Maniatis
Journal:  Mol Cell Biol       Date:  1992-08       Impact factor: 4.272

6.  Infection of cultured bovine cells with bovine herpesvirus 1 (BHV-1) or Sendai virus induces different beta interferon subtypes.

Authors:  Leticia Frizzo da Silva; Clinton Jones
Journal:  Virus Res       Date:  2011-02-23       Impact factor: 3.303

7.  Interferon regulatory factor-1 (IRF-1) activates the synthetic IRF-1-responsive sequence (GAAAGT)4 in Saccharomyces cerevisiae.

Authors:  A Sailer; K Nagata; D Näf; M Aebi; C Weissmann
Journal:  Gene Expr       Date:  1992

8.  Structure and regulation of the human interferon regulatory factor 1 (IRF-1) and IRF-2 genes: implications for a gene network in the interferon system.

Authors:  H Harada; E Takahashi; S Itoh; K Harada; T A Hori; T Taniguchi
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

9.  Proteolytic degradation of MAD3 (I kappa B alpha) and enhanced processing of the NF-kappa B precursor p105 are obligatory steps in the activation of NF-kappa B.

Authors:  K H Mellits; R T Hay; S Goodbourn
Journal:  Nucleic Acids Res       Date:  1993-11-11       Impact factor: 16.971

10.  Defining therapeutic targets by using adenovirus: blocking NF-kappaB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators.

Authors:  J Bondeson; B Foxwell; F Brennan; M Feldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.